Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2020-08-31 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于公司向特定对象发行股票之发行保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行保荐书" (Issuance Sponsorship Letter) related to Shenzhen BGI Genomics Co., Ltd. issuing shares to specific investors. It is issued by CITIC Securities as the sponsor. The content includes detailed information about the issuance, the sponsor's due diligence, legal and regulatory compliance, financial data, risk disclosures, and the sponsor's recommendation for the issuance. This type of document is a formal sponsorship letter or prospectus related to a capital raising event, specifically a private placement or non-public issuance of shares. It is not an annual report, earnings release, or management report. It is not a simple announcement but a comprehensive document supporting a capital issuance. Therefore, the document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2020-08-31 Chinese
最近一年的财务报告及其审计报告以及最近一期的财务报告
Regulatory Filings
2020-08-31 Chinese
国浩律师（深圳）事务所关于公司向特定对象发行股票之法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm (国浩律师（深圳）事务所) regarding Shenzhen BGI Genomics Co., Ltd.'s issuance of shares to specific investors. It extensively discusses the legal compliance, approval, authorization, and conditions related to a specific stock issuance event. The document includes detailed legal analysis, references to relevant laws and regulations, and verification of the company's qualifications and procedures for the issuance. It is not a financial report, earnings release, or management discussion but a legal opinion related to a capital raising event. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2020-08-31 Chinese
向特定对象发行股票募集说明书（申报稿）
Capital/Financing Update Classification · 95% confidence The document is titled "深圳华大基因股份有限公司 向特定对象发行股票募集说明书 (申报稿)" which translates to "BGI Genomics Co., Ltd. Private Placement Stock Offering Prospectus (Draft)". It contains detailed sections on the issuer's basic information, shareholding structure, industry characteristics, business model, fundraising background and purpose, use of proceeds, risk factors, and various legal and financial statements. The document is a comprehensive disclosure related to a specific stock issuance to targeted investors, including detailed financial and operational data, shareholder information, and regulatory compliance statements. This type of document is a prospectus or offering memorandum related to capital raising through a private placement of shares. According to the provided filing definitions, the category that best fits this document is "Capital/Financing Update (CAP)" because it provides updates on company fundraising and financing activities. The document is not an annual or interim report, audit report, or earnings release, nor is it a proxy or voting announcement. It is a detailed disclosure related to a capital raising event.
2020-08-31 Chinese
20华大02公司债券担保人深圳担保集团有限公司2020年半年度财务报表（未经审计）
Regulatory Filings
2020-08-27 Chinese
20华大01公司债券担保人深圳市高新投融资担保有限公司2020年半年度财务报表（未经审计）
Regulatory Filings
2020-08-27 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.